|PubChem CID 66550890|
3D model (Jmol) Interactive image
|PubChem SID 152143555|
Molar mass 556.5 g/mol
New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and it currently being studied in clinical trials.